Clinical Trial Supplies

Cutting High Costs

Due to high costs and strict handling requirements for many biopharmaceutical products entering clinical development, the logistics of clinical trial supplies are more critical than ever. Avoiding overproduction, oversupply, and inventory expiration will lower costs with some study drugs, which can reach tens of millions of dollars.

Dealing With Stringent Handling Requirements

Investigational Medicinal Products (IMPs) must also be manufactured in strict accordance with GMP, utilizing labeling and packaging that match the trial protocol. Equally important, the importation and distribution of IMPs and comparator drugs require extensive planning and knowledge of myriad country-specific customs regulations to ensure that shipments are not delayed. As a result, sponsors will experience a significant reduction in drug overproduction and overstocking costs, decrease the risk of expired inventory, avoid customs delays, and prevent drug supply shortfalls that may jeopardize a trial.